Search
Alzheimer's Disease Paid Clinical Trials in Oregon
A listing of 13 Alzheimer's Disease clinical trials in Oregon actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 13 of 13
The state of Oregon currently has 13 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Portland, Eugene, Medford and Clackamas.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Digital Evaluations and Technologies Enabling Clinical Translation for AD
Recruiting
The DETECT-AD study (stands for "Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease") is a new study designed to improve clinical trials for early Alzheimer's disease. DETECT-AD uses specialized home-based digital devices (electronic scale, electronic pill box, under-the-mattress sleep sensor, motion activity sensors, wrist watch activity tracker, driving sensor, and computer software) to see if the devices will improve clinical trial assessments. This 36-... Read More
Gender:
ALL
Ages:
65 years and above
Trial Updated:
12/05/2023
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Alzheimer Disease, Early Onset
13 - 13 of 13